NASDAQ: IBRX · Biotechnology
Over the past week, ImmunityBio (IBRX) pulled in about 488 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 39% bullish but is sharply divided: X runs 58% bullish while Reddit sits at just 20%. Wall Street is more constructive, with 4 of 4 analysts rating IBRX a buy.
There is steady buzz around IBRX this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 100% buy share sits next to a crowd that ranges from Reddit at 20% to X at 58%. No other tracker puts the two side by side.
4 analysts have weighed in: a Strong Buy consensus: 4 buy calls against 0 sell, with an average 12-month price target of $12.75.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 61 points above the crowd average of 39%, the professionals are more constructive than retail. The split is inside the crowd: X reads 58% bullish while Reddit sits at 20%, a 38-point spread that single-source trackers miss.
Over the 30-day window, ImmunityBio (IBRX) buzz held moderate around 49.8 while the price drifted up 32.9% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 14.5M shares. Updated Oct 10, 2026. Over the last 7 trading days, IBRX gained 13.3%. Buzz activity in the recent week averaged 50.5 and was relatively stable, swinging between 42.1 and 60.0. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 21 of the 21 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for IBRX and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live IBRX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 10, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (4 / 0 / 0) |
| Crowd bullish (7d) | 39% |
| Avg price target | $12.75 |
| Most bullish source | X, 58% |
| Most bearish source | Reddit, 20% |
| Sentiment spread | 38 pts |
| Mentions (7d) | 488 |
| Market cap | $10.5B |
| P/E · Forward P/E | n/a · 123.5 |
| EPS · Beta | -$0.96 · 0.0 |
| Revenue (TTM) | $165.8M · 0% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, ImmunityBio (IBRX) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 39% bullish across 3 active sources. Those sources contribute 488 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around ImmunityBio (IBRX) is fairly quiet with 35 mentions over the last 7 days; the 30-day context spans 12 tracked subreddits. The 7-day tone is 20% bullish; 3-day activity momentum is falling, suggesting cooling attention.
The crowd reads bearish on ImmunityBio (IBRX), averaging 39% bullish across 3 tracked sources over the last 7 days. The two ends of the range are X at 58% bullish and Reddit at 20%, a 38-point spread. On the professional side, 4 of 4 analysts rate IBRX a buy.
Of the 4 analysts covering ImmunityBio (IBRX), 4 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $12.75. That puts the street ahead of the crowd, which averages 39% bullish.
ImmunityBio (IBRX)'s cross-source average is bearish at 39% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. X reads 58% bullish, News reads 38% bullish and reddit coverage is the most negative at 20% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for ImmunityBio (IBRX) at 39% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. The most bearish reading is reddit at 20% bullish. 3-day activity momentum is falling on Reddit and X, while news activity is rising. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 437 mentions (90% of total volume). Reddit contributes 35 mentions and News contributes 16 mentions. The cross-source average is bearish at 39% bullish, while news is the only source with rising 3-day activity. Source readings are split: 1 source leans bullish and 2 sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. IBRX's sell signal at 93/100 conviction reflects a bearish cross-source average at 39% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. It is a research shortcut, not financial advice.
The IBRX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key